Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Treating Breast Cancer in Men Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women. by Marilyn Fenichel Forward Look A Matter of Age Cell and molecular biologist Ashani Weeraratna discusses how older patients respond to immunotherapy. by Sue Rochman Forward Look Treating Head and Neck Skin Cancers A study suggests high-risk patients do not need chemotherapy. by Stephen Ornes Forward Look Breaking Down Breakthrough Cancer Therapies Drugs approved through this pathway may have limited evidence. by Lindsey Konkel Tomorrow’s Trials New tools are being integrated into the research process to ease patients’ access to clinical trials and improve their experience. by Bradley Jones Forward Look What’s Next? Off-the-shelf equivalents to CAR-T cell therapy are emerging. by Bradley Jones From the Editor-In-Chief Improving Health After Treatment The U.S. health care system must adapt to the needs of cancer survivors. by William G. Nelson, MD, PhD Getting a Read on Cancer Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies. by Kate Yandell next Cancer Talk Considering the Term “Cancer Survivor” A study investigates how people who have been diagnosed with cancer feel about being called survivors. by Jen Tota McGivney Making Clinical Trials More Inclusive Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment. by Ashley P. Taylor What Do Clinical Trial Endpoints Really Measure? A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life. by Jon Kelvey Shingles Risk Increased for Cancer Patients A new vaccine is safe for cancer patients but hard to find. by Nancy Averett More Posts